Sascha Berger to join as NEOM's Investment Director for Biotech

 

Sascha Berger appointed as NEOM's Investment Director for Biotech

Sascha Berger has been appointed as the Investment Director for Biotech at NEOM, the ambitious special economic zone in Saudi Arabia.

In his new role, Berger will be responsible for shaping NEOM’s global investment strategy in the biotech and medtech sectors. While based in Saudi Arabia, his role encompasses a global scope.

 

Read More       NEOM's paradigm-shifting approach to personalized health and innovation

 

On LinkedIn, Berger expressed his enthusiasm: “NEOM is not just a place but a visionary project aimed at becoming a hub for innovation and sustainable living. I’m thrilled to contribute to this mission by driving strategic investments in the life sciences sector.”

Berger will work closely with Jordi Naval, who leads NEOM’s biotech initiatives, and will also collaborate with the NEOM Investment Fund (NIF), the strategic investment arm of NEOM. Within NIF, he will engage with Babar Kahn, a prominent advocate for biotech investments.

 

Read More       Startup Creasphere joins forces with NEOM's health, wellbeing & biotech sector

 

The investment strategy under Berger’s leadership will prioritize two main areas:

1. Lighthouse Projects: Initiatives designed to create immediate impact.
2. Moonshot Investments: Long-term ventures aimed at shaping the future of biotech.

Berger’s appointment marks a significant step in advancing NEOM’s commitment to innovation and sustainable development in the biotech field.

Source: https://www.investorsinhealthcare.com/